180 related articles for article (PubMed ID: 18701279)
21. Glucose-based spiro-heterocycles as potent inhibitors of glycogen phosphorylase.
Nagy V; Benltifa M; Vidal S; Berzsényi E; Teilhet C; Czifrák K; Batta G; Docsa T; Gergely P; Somsák L; Praly JP
Bioorg Med Chem; 2009 Aug; 17(15):5696-707. PubMed ID: 19574053
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of variously coupled conjugates of D-glucose, 1,3,4-oxadiazole, and 1,2,3-triazole for inhibition of glycogen phosphorylase.
Kun S; Nagy GZ; Tóth M; Czecze L; Van Nhien AN; Docsa T; Gergely P; Charavgi MD; Skourti PV; Chrysina ED; Patonay T; Somsák L
Carbohydr Res; 2011 Sep; 346(12):1427-38. PubMed ID: 21470596
[TBL] [Abstract][Full Text] [Related]
23. The crystal structure of human muscle glycogen phosphorylase a with bound glucose and AMP: an intermediate conformation with T-state and R-state features.
Lukacs CM; Oikonomakos NG; Crowther RL; Hong LN; Kammlott RU; Levin W; Li S; Liu CM; Lucas-McGady D; Pietranico S; Reik L
Proteins; 2006 Jun; 63(4):1123-6. PubMed ID: 16523484
[No Abstract] [Full Text] [Related]
24. Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a.
Onda K; Suzuki T; Shiraki R; Yonetoku Y; Negoro K; Momose K; Katayama N; Orita M; Yamaguchi T; Ohta M; Tsukamoto S
Bioorg Med Chem; 2008 May; 16(10):5452-64. PubMed ID: 18434170
[TBL] [Abstract][Full Text] [Related]
25. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.
Kristiansen M; Andersen B; Iversen LF; Westergaard N
J Med Chem; 2004 Jul; 47(14):3537-45. PubMed ID: 15214781
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of oleanolic acid dimers as inhibitors of glycogen phosphorylase.
Cheng K; Liu J; Sun H; Xie J
Chem Biodivers; 2010 Mar; 7(3):690-7. PubMed ID: 20232331
[TBL] [Abstract][Full Text] [Related]
27. Advances in glycogen phosphorylase inhibitor design.
Oikonomakos NG; Somsák L
Curr Opin Investig Drugs; 2008 Apr; 9(4):379-95. PubMed ID: 18393105
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of 2-(β-D-glucopyranosyl)-5-(substituted-amino)-1,3,4-oxa- and -thiadiazoles for the inhibition of glycogen phosphorylase.
Szőcs B; Tóth M; Docsa T; Gergely P; Somsák L
Carbohydr Res; 2013 Nov; 381():187-95. PubMed ID: 23582340
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of tartaric acid analogues of FR258900 and their evaluation as glycogen phosphorylase inhibitors.
Varga G; Docsa T; Gergely P; Juhász L; Somsák L
Bioorg Med Chem Lett; 2013 Mar; 23(6):1789-92. PubMed ID: 23395662
[TBL] [Abstract][Full Text] [Related]
30. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection.
Watson KA; Mitchell EP; Johnson LN; Cruciani G; Son JC; Bichard CJ; Fleet GW; Oikonomakos NG; Kontou M; Zographos SE
Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):458-72. PubMed ID: 15299833
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of C-xylopyranosyl- and xylopyranosylidene-spiro-heterocycles as potential inhibitors of glycogen phosphorylase.
Somsák L; Bokor É; Czibere B; Czifrák K; Koppány C; Kulcsár L; Kun S; Szilágyi E; Tóth M; Docsa T; Gergely P
Carbohydr Res; 2014 Nov; 399():38-48. PubMed ID: 25081322
[TBL] [Abstract][Full Text] [Related]
32. Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
Hadjiloi T; Tiraidis C; Chrysina ED; Leonidas DD; Oikonomakos NG; Tsipos P; Gimisis T
Bioorg Med Chem; 2006 Jun; 14(11):3872-82. PubMed ID: 16464598
[TBL] [Abstract][Full Text] [Related]
33. Kinetic and crystallographic studies of glucopyranosylidene spirothiohydantoin binding to glycogen phosphorylase B.
Oikonomakos NG; Skamnaki VT; Osz E; Szilágyi L; Somsák L; Docsa T; Tóth B; Gergely P
Bioorg Med Chem; 2002 Feb; 10(2):261-8. PubMed ID: 11741774
[TBL] [Abstract][Full Text] [Related]
34. Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studies.
Whittamore PR; Addie MS; Bennett SN; Birch AM; Butters M; Godfrey L; Kenny PW; Morley AD; Murray PM; Oikonomakos NG; Otterbein LR; Pannifer AD; Parker JS; Readman K; Siedlecki PS; Schofield P; Stocker A; Taylor MJ; Townsend LA; Whalley DP; Whitehouse J
Bioorg Med Chem Lett; 2006 Nov; 16(21):5567-71. PubMed ID: 16945526
[TBL] [Abstract][Full Text] [Related]
35. Enzyme kinetics of muscle glycogen phosphorylase b.
Walcott S; Lehman SL
Biochemistry; 2007 Oct; 46(42):11957-68. PubMed ID: 17910419
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of novel hyphodermin derivatives as glycogen phosphorylase a inhibitors.
Loughlin WA; Pierens GK; Petersson MJ; Henderson LC; Healy PC
Bioorg Med Chem; 2008 Jun; 16(11):6172-8. PubMed ID: 18485716
[TBL] [Abstract][Full Text] [Related]
37. Discovery of a series of indan carboxylic acid glycogen phosphorylase inhibitors.
Bennett SN; Campbell AD; Hancock A; Johnstone C; Kenny PW; Pickup A; Plowright AT; Selmi N; Simpson I; Stocker A; Whalley DP; Whittamore PR
Bioorg Med Chem Lett; 2010 Jun; 20(12):3511-4. PubMed ID: 20493691
[TBL] [Abstract][Full Text] [Related]
38. Structure based inhibitor design targeting glycogen phosphorylase B. Virtual screening, synthesis, biochemical and biological assessment of novel N-acyl-β-d-glucopyranosylamines.
Parmenopoulou V; Kantsadi AL; Tsirkone VG; Chatzileontiadou DS; Manta S; Zographos SE; Molfeta C; Archontis G; Agius L; Hayes JM; Leonidas DD; Komiotis D
Bioorg Med Chem; 2014 Sep; 22(17):4810-25. PubMed ID: 25092521
[TBL] [Abstract][Full Text] [Related]
39. Discovery of novel dual-action antidiabetic agents that inhibit glycogen phosphorylase and activate glucokinase.
Zhang L; Chen X; Liu J; Zhu Q; Leng Y; Luo X; Jiang H; Liu H
Eur J Med Chem; 2012 Dec; 58():624-39. PubMed ID: 23178962
[TBL] [Abstract][Full Text] [Related]
40. The architecture of hydrogen and sulfur σ-hole interactions explain differences in the inhibitory potency of C-β-d-glucopyranosyl thiazoles, imidazoles and an N-β-d glucopyranosyl tetrazole for human liver glycogen phosphorylase and offer new insights to structure-based design.
Kyriakis E; Karra AG; Papaioannou O; Solovou T; Skamnaki VT; Liggri PGV; Zographos SE; Szennyes E; Bokor É; Kun S; Psarra AG; Somsák L; Leonidas DD
Bioorg Med Chem; 2020 Jan; 28(1):115196. PubMed ID: 31767404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
